Navigation Links
ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011
Date:6/17/2011

PHILADELPHIA, June 17, 2011 /PRNewswire/ -- ERT (NASDAQ: ERT), announced today that Keith Schneck, the Company's Chief Financial Officer, is scheduled to present at the 2011 Wells Fargo Securities Healthcare Conference at 1:30 PM ET on Thursday, June 23, 2011 in Boston.

Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com. The webcast may also be accessed at http://cc.talkpoint.com/well001/062211a_cy/?entity=46_YPI335L.  The webcast will be available via replay for 90 days.

About ERT

ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic Patient Reported Outcomes (ePRO) in multiple modalities across all phases of clinical research.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Media Contact:
Keith Schneck, CFO
Tel: 215-972-0420
kschneck@ert.com


'/>"/>
SOURCE ERT
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... -- www.Financialbuzz.com - The cannabis market ... the United States as eight more states had ... 64, the California Cannabis Legalization Initiative, was passed by a ... 2016. This outcome means that individuals in California ... certain amount of cannabis for personal use. According to a ...
(Date:1/24/2017)... 2017   QR Pharma , Inc., a ... therapies for the treatment of Alzheimer,s, Parkinson,s and ... four world-class key opinion leaders to its Scientific ... Pharma,s previous roster of impressive advisors in order ... the development of the breakthrough mechanism of action ...
(Date:1/24/2017)... Mezzion has filed a suit for damages ... that Dr. Reddy,s committed fraud relating to Dr. Reddy,s ... (FDA) cGMP practices, and misrepresenting its compliance to Mezzion.  ... Mezzion that it was compliant with FDA regulations, and ... also states that Dr. Reddy,s misconduct was the sole ...
Breaking Medicine Technology:
(Date:1/24/2017)... Mass. (PRWEB) , ... January 24, 2017 , ... ... company to visualize, detect, and eliminate cyber threats in real-time, today announced a ... This partnership will enable customers to monitor, respond and protect their critical information ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Center ... 21st century leadership, has named Hector M. Chavez, Manager, Employee & Labor Relations at ... center - as its Hispanic Leader of the Month. City of Hope is committed ...
(Date:1/24/2017)... Santa Rosa, CA (PRWEB) , ... January 24, 2017 , ... ... rates is good news for everyone and particularly good news for prostate cancer patients: ... from the diagnosis. , According to the report the cancer death rate has dropped ...
(Date:1/24/2017)... ... January 24, 2017 , ... A yellow fever outbreak in Brazil ... month. Yellow fever is primarily spread through contact with infected mosquitos. The outbreak has ... to prevent its spread. , According to multiple health organizations, the best way to ...
(Date:1/24/2017)... ... January 24, 2017 , ... “Spiritual Vitamins: ... the connection with God. “Spiritual Vitamins: A Spiritual Energy Booster” is the creation ... Faith Publishing, Mathai Yohannan’s new book engages the mind and spirit in a ...
Breaking Medicine News(10 mins):